KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2016 - 2025)

Teva Pharmaceutical Industries (TEVA) has disclosed Asset Utilization Ratio for 9 consecutive years, with 0.43 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 4.94% year-over-year to 0.43, compared with a TTM value of 0.43 through Dec 2025, up 4.94%, and an annual FY2025 reading of 0.43, up 7.87% over the prior year.
  • Asset Utilization Ratio was 0.43 for Q4 2025 at Teva Pharmaceutical Industries, up from 0.42 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.43 in Q4 2025 and bottomed at 0.33 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.36, with a median of 0.34 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio decreased 0.16% in 2022, then rose 10.19% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.33 in 2021, then rose by 1.72% to 0.34 in 2022, then grew by 9.5% to 0.37 in 2023, then increased by 10.19% to 0.41 in 2024, then rose by 4.94% to 0.43 in 2025.
  • Business Quant data shows Asset Utilization Ratio for TEVA at 0.43 in Q4 2025, 0.42 in Q3 2025, and 0.42 in Q2 2025.